you really crack me up Sherlock, maybe you should try reading ASX announcement especially this one that went out a week before the meeting
"Since the Antares Notice of Meeting was sent to Noteholders, the Company has been in discussions with Noteholders. As a result of these discussions, the Company is intending to propose a number of amendments to ‘Resolution 1 – Amendments to Trust Deed’ to be put to Noteholders at the Meeting for the Noteholders to consider and, if thought fit, to pass, with or without amendment.
Resolution 1 of the Antares Notice of Meeting currently seeks the following amendments to the trust deed ("Trust Deed") for Antares' convertible notes ("Notes"), to:
1. extend the reset date for the Notes to 31 March 2017;
2. place a moratorium on the payment of any interest from 31 January 2016 to 30 April 2017; and
3. increase the conversation rate for Noteholders so that one Note is convertible into four ordinary shares in Antares.
The amended resolution will also include the following amendments to the Trust Deed:
1. appointment of Noteholder nominee to the Company's Board;
2. subject to receipt of sufficient funds, ability for Noteholders to redeem following completion of disposal of the Projects;
3. subject to receipt of sufficient funds, additional exit payment to be paid to Noteholders; and
4. providing a mechanic for the Notes to become secured.
- Forums
- ASX - By Stock
- AZZ
- Ann: Chairman's Letter to Noteholders
Ann: Chairman's Letter to Noteholders, page-138
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AZZ (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online